Short answer · Medically reviewed summary · Last updated: 2026-05-08
Lynch Syndrome is a hereditary cancer predisposition syndrome caused by a germline mutation in one of the DNA mismatch repair (MMR) genes. These mutations prevent the body from effectively repairing errors that occur when DNA replicates, significantly increasing the lifetime risk of developing colorectal and various other cancers. What are the genetic causes of Lynch Syndrome? The primary cause of Lynch Syndrome is a pathogenic variant (mutation) in one of the mismatch repair genes: MLH1, MSH2, MSH6, or PMS2.
1 people with Lynch Syndrome have shared their first-person experience on this question at DiseaseMaps.
Lynch Syndrome is a hereditary cancer predisposition syndrome caused by a germline mutation in one of the DNA mismatch repair (MMR) genes. These mutations prevent the body from effectively repairing errors that occur when DNA replicates, significantly increasing the lifetime risk of developing colorectal and various other cancers.
The primary cause of Lynch Syndrome is a pathogenic variant (mutation) in one of the mismatch repair genes: MLH1, MSH2, MSH6, or PMS2. Additionally, mutations in the EPCAM gene can lead to Lynch Syndrome by silencing the MSH2 gene. Think of these genes as the body’s "spell-check" system; when they are faulty, DNA copying errors accumulate, which can eventually lead to the uncontrolled cell growth characteristic of cancer.
Yes, Lynch Syndrome follows an autosomal dominant inheritance pattern. This means that if one parent carries the mutation, there is a 50% chance that each child will inherit the genetic predisposition. Because Lynch Syndrome is genetic, it is present from birth in every cell of the body, though it does not guarantee that an individual will develop cancer.
The cause of Lynch Syndrome is strictly the genetic mutation inherited from a parent. In contrast, risk factors are secondary influences that may increase the probability or speed at which cancer develops in those already carrying the mutation. These include:
While the genetic etiology of Lynch Syndrome is well-understood, ongoing research focuses on precision prevention. Scientists are investigating aspirin chemoprevention and immunotherapy treatments that target the high mutation burden found in tumors associated with Lynch Syndrome. Currently, 79 members of the DiseaseMaps community are actively sharing their experiences to help researchers better understand the clinical variability of this condition.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.